HRP20031026B1 - Amino benzoksazol sulfonamidni inhibitori hiv proteaze širokog spektra - Google Patents

Amino benzoksazol sulfonamidni inhibitori hiv proteaze širokog spektra

Info

Publication number
HRP20031026B1
HRP20031026B1 HRP20031026AA HRP20031026A HRP20031026B1 HR P20031026 B1 HRP20031026 B1 HR P20031026B1 HR P20031026A A HRP20031026A A HR P20031026AA HR P20031026 A HRP20031026 A HR P20031026A HR P20031026 B1 HRP20031026 B1 HR P20031026B1
Authority
HR
Croatia
Prior art keywords
het
alkyl
cycloalkyl
aryl
group
Prior art date
Application number
HRP20031026AA
Other languages
English (en)
Croatian (hr)
Inventor
Dominique@Louis@Nestor@Ghislai@Surleraux
Sandrine@Marie@Helene@Vendeville
Wim@Gaston@Verschueren
Marie@Pierre@T@M@M@G@De@Bethune
Herman@Augustinus@De@Kock
Abdellah@Tahri
Original Assignee
Tibotec@Pharmaceuticals@Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec@Pharmaceuticals@Ltd filed Critical Tibotec@Pharmaceuticals@Ltd
Publication of HRP20031026A2 publication Critical patent/HRP20031026A2/hr
Publication of HRP20031026B1 publication Critical patent/HRP20031026B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20031026AA 2001-05-11 2002-05-10 Amino benzoksazol sulfonamidni inhibitori hiv proteaze širokog spektra HRP20031026B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201732 2001-05-11
PCT/EP2002/005212 WO2002092595A1 (en) 2001-05-11 2002-05-10 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Publications (2)

Publication Number Publication Date
HRP20031026A2 HRP20031026A2 (en) 2005-10-31
HRP20031026B1 true HRP20031026B1 (hr) 2012-07-31

Family

ID=8180286

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20031026AA HRP20031026B1 (hr) 2001-05-11 2002-05-10 Amino benzoksazol sulfonamidni inhibitori hiv proteaze širokog spektra

Country Status (31)

Country Link
US (2) US7622490B2 (de)
EP (1) EP1387842B1 (de)
JP (1) JP4467889B2 (de)
KR (1) KR100878853B1 (de)
CN (1) CN100549007C (de)
AP (1) AP1652A (de)
AR (1) AR035970A1 (de)
AT (1) ATE429431T1 (de)
AU (1) AU2002310818B2 (de)
BG (1) BG66350B1 (de)
BR (1) BR0209594A (de)
CA (1) CA2444895C (de)
CY (1) CY1109247T1 (de)
CZ (1) CZ304524B6 (de)
DE (1) DE60232067D1 (de)
DK (1) DK1387842T3 (de)
EA (1) EA009590B1 (de)
EE (1) EE05307B1 (de)
ES (1) ES2325809T3 (de)
HR (1) HRP20031026B1 (de)
HU (1) HUP0400438A3 (de)
IL (1) IL158093A0 (de)
MX (1) MXPA03010258A (de)
NO (1) NO326883B1 (de)
NZ (1) NZ529250A (de)
OA (1) OA13134A (de)
PL (1) PL209029B1 (de)
PT (1) PT1387842E (de)
SK (1) SK287952B6 (de)
WO (1) WO2002092595A1 (de)
ZA (1) ZA200307799B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (de) 1999-11-12 2006-06-14 Abbott Laboratories Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7109230B2 (en) 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2005030739A1 (en) * 2003-09-30 2005-04-07 Tibotec Pharmaceuticals Ltd. Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
US8193227B2 (en) 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
JP4818124B2 (ja) 2003-12-23 2011-11-16 テイボテク・フアーマシユーチカルズ・リミテツド （３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法
KR101192859B1 (ko) 2003-12-23 2012-10-19 얀센 알 앤드 디 아일랜드 （3ｒ,3ａｓ,6ａｒ）-헥사하이드로푸로〔2,3-ｂ〕푸란-3-일（1ｓ,2ｒ）-3-〔〔（4-아미노페닐）설포닐〕（이소부틸）아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US20120220520A1 (en) * 2006-10-17 2012-08-30 Van T Klooster Gerben Albert Eleutherius Bioavailable combinations for hcv treatment
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028464A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028418A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997018205A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204879D0 (sv) 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE69121436T2 (de) 1990-03-09 1997-01-09 Milliken Res Corp Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
CA2142998C (en) * 1992-08-25 2008-01-29 Michael L. Vazquez N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
ES2166786T3 (es) 1993-10-01 2002-05-01 Astrazeneca Ab Procedimiento i.
DE69637380T2 (de) 1995-01-20 2009-09-17 G.D. Searle Llc, Chicago Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
CN1149223C (zh) 1995-03-10 2004-05-12 G·D·瑟尔公司 杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
US6509038B2 (en) 1996-05-20 2003-01-21 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
CZ295502B6 (cs) 1997-03-26 2005-08-17 Janssen Pharmaceutica N. V. Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
GB9717849D0 (en) 1997-08-23 1997-10-29 Seal Sands Chemicals Limited Preparation of pyridene derivatives
EP1042280A2 (de) 1997-12-24 2000-10-11 Vertex Pharmaceuticals Incorporated Prodrugs von aspartyl-proteaseinhibitoren
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt) 1998-06-23 2016-10-19 The Board Of Trustees Of The Univ Of Illionis Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
EP1397367A2 (de) * 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Breitspektrum-2-(amino substituierte)-benzoxazol-sulfonamid-hiv-protease-inhibitoren für die entdeckung entfernter zellulärer signale durch nukleozytoplasmatisches zyklisieren

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006030A1 (en) * 1993-08-24 1995-03-02 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
WO1996028464A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028418A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1996028463A1 (en) * 1995-03-10 1996-09-19 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
WO1997018205A1 (en) * 1995-11-15 1997-05-22 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

Also Published As

Publication number Publication date
BG66350B1 (bg) 2013-08-30
CN1507446A (zh) 2004-06-23
IL158093A0 (en) 2004-03-28
EA200301234A1 (ru) 2004-04-29
US20040106661A1 (en) 2004-06-03
ES2325809T3 (es) 2009-09-18
HRP20031026A2 (en) 2005-10-31
CZ304524B6 (cs) 2014-06-18
MXPA03010258A (es) 2005-03-07
CN100549007C (zh) 2009-10-14
AR035970A1 (es) 2004-07-28
EE05307B1 (et) 2010-06-15
EA009590B1 (ru) 2008-02-28
US7863306B2 (en) 2011-01-04
DK1387842T3 (da) 2009-08-10
JP4467889B2 (ja) 2010-05-26
OA13134A (en) 2006-12-13
HUP0400438A2 (hu) 2004-08-30
AP1652A (en) 2006-08-11
EE200300547A (et) 2004-02-16
KR100878853B1 (ko) 2009-01-15
NO20034988D0 (no) 2003-11-10
PT1387842E (pt) 2009-07-20
NZ529250A (en) 2005-05-27
CA2444895A1 (en) 2002-11-21
CA2444895C (en) 2011-02-15
CY1109247T1 (el) 2014-07-02
DE60232067D1 (de) 2009-06-04
PL366780A1 (en) 2005-02-07
WO2002092595A1 (en) 2002-11-21
US20100029632A1 (en) 2010-02-04
ZA200307799B (en) 2005-03-30
EP1387842A1 (de) 2004-02-11
NO326883B1 (no) 2009-03-09
BR0209594A (pt) 2004-03-30
JP2004534757A (ja) 2004-11-18
SK14902003A3 (sk) 2004-07-07
AP2003002904A0 (en) 2003-12-31
KR20040022417A (ko) 2004-03-12
HK1062912A1 (en) 2004-12-03
SK287952B6 (sk) 2012-06-04
HUP0400438A3 (en) 2007-08-28
AU2002310818B2 (en) 2007-12-13
ATE429431T1 (de) 2009-05-15
EP1387842B1 (de) 2009-04-22
US7622490B2 (en) 2009-11-24
BG108309A (bg) 2004-12-30
PL209029B1 (pl) 2011-07-29
CZ20033290A3 (cs) 2004-05-12

Similar Documents

Publication Publication Date Title
ES2618630T3 (es) Composiciones terapéuticas y métodos de uso relacionados
CO5180537A1 (es) Nuevos derivados de hexa-, penta- y tetra-peptidos como inhibidores de la hepatitis c. comprendiendo sus racematos, diastereoisomeros e isomeros opticos y procedimiento para la preparacion de los mismos
ES2259113T3 (es) Inhibidores del factor xa y de otras serinproteasas implicadas en la cascada de coagulacion.
HRP20010200B1 (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
CO6251257A2 (es) Derivados de guanina policiclicos y sus metodos de uso
AR044342A1 (es) Derivados de bencimidazol
HRP20030735B1 (en) Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
AR033793A1 (es) Compuestos derivados del benceno, su utilizacion, procedimientos para su preparacion y composiciones farmaceuticas que los contienen
CO4970713A1 (es) Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
HRP20050895B1 (hr) Ftalazinon derivati
HRP20020541B1 (en) Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
CO6190523A2 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
DE60209497D1 (de) Schmierölzusammensetzung enthaltend ein gemisch aus carboxylsäuren und aminen als rostschutzmittel
AR010324A1 (es) Composiciones limpiadoras liquidas que contienen sales de n-alquil amonio acetonitrilo
AR072428A1 (es) Derivados de pirimidin nucleotidos inhibidores de polimerasas del virus de la hepatitis c (vhc), composiciones farmaceuticas que los contienen y metodo para prepararlos.
ECSP11010838A (es) Derivados de benzazepina y sus usos como antagonistas de histamina h3
AR069435A1 (es) Derivados de aminotiazol, proceso para la obtencion de los mismos, composiciones farmaceuticas y su uso como inhibidores de la fbpasa
HRP20020317B1 (en) Pharmaceutically active compounds
DE60315615D1 (de) Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten
AR064675A1 (es) Derivados heterociclicos de pirrolo- [2,3-b] piridina, inhibidores de proteinquinasas plk, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos en trastornos hiperproliferativos
CO4920234A1 (es) Derivados de acidos arilsulfonilaminomidroxamicos
CO5170502A1 (es) Derivados de 1-carboxi-n-cyclopropyl-4-(quinolin o naftil -4-iloxi) pirrolidin-2-carboxamide y sus composiciones farmaceuticas
EA200300558A1 (ru) Агонисты альфа-рецепторов, активируемых пролифератором пероксисомы
CO5631434A2 (es) Derivados de piridina-carboxamida y su uso como plaguicidas
AR046996A1 (es) Derivados de amino-pirimidinas

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150408

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20160510